The health ministry said there has been “rampant use of this experimental therapy despite limited knowledge of its safety and efficacy” and little evidence to show any clinical benefits.
The health ministry said there has been “rampant use of this experimental therapy despite limited knowledge of its safety and efficacy” and little evidence to show any clinical benefits.
<iframe src="https://hindustansphere.com/embed/cluster/f2fb739554c79d0be71a7b425f785ed52baf23e8" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="India issues strict curbs, oversight on stem cell therapy for critical limb ischemia and chronic wounds"></iframe>
The health ministry said there has been “rampant use of this experimental therapy despite limited knowledge of its safety and efficacy” and little evidence to show any clinical benefits.
